Aptorum files amended 8-K updating DiamiR Biosciences financial statementsPUBT·Aug 21 at 09:18 PMAPM0.00%NIKI-3.50%
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% StakeTradingView·Jul 24 at 08:36 PMNIKI-3.50%APM0.00%
Niki BioSolutions falls 9% as gains fade after gene testing dealUS Stock Market Update·Jul 23 at 07:10 PMNIKI-3.50%
Niki BioSolutions falls 5% as early 44% surge fadesUS Stock Market Update·Jul 23 at 05:32 PMNIKI-3.50%
Niki BioSolutions climbs 2% on APOE testing deal after 44% premarket surgeUS Stock Market Update·Jul 23 at 02:00 PMNIKI-3.50%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 12:06 PMSXTC-3.91%HYFT-2.99%
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.benzinga_article·Jul 23 at 12:04 PMNIKI-3.50%
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)Unusual Whales·Jul 23 at 12:03 PMNIKI-3.50%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 05:05 PMTELO-1.79%CPHI-0.02%
The Market's Misfits: Who is Faking It and Who is Building the Future?Global Report·Jul 21 at 09:13 AMCSIQ+2.68%AVEX-4.03%
Aptorum Group Provides Update on DiamiR Biosciences Merger | APM Stock NewsStockTitan·Jul 16 at 07:00 AMAPM0.00%NIKI-3.50%
Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutionsPUBT·Jul 8 at 12:04 PMAPM0.00%NIKI-3.50%
Aptorum amends 6-K to extend DiamiR merger termination date to July 31, 2026PUBT·Jun 22 at 09:01 PMAPM0.00%NIKI-3.50%